Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/30/1995 | CA2190635A1 Method for stabilizing duocarmycin derivatives |
11/30/1995 | CA2190606A1 Antimicrobial oil-in-water emulsions |
11/30/1995 | CA2190604A1 Antibacterial oil-in-water emulsions |
11/29/1995 | EP0684044A2 Composition consisting of a dendrimer and an active substance |
11/29/1995 | EP0684042A2 Oral solid pharmaceutical compositions containing as active ingredient gemfibrozil and process for preparing them |
11/29/1995 | EP0683804A1 Methods of polymer impregnation |
11/29/1995 | EP0683670A1 Wound-healing compositions containing iodine and a non-reducing sugar |
11/29/1995 | EP0683668A1 Compositions and methods for transdermal drug delivery |
11/29/1995 | EP0683665A1 Magnetically responsive composition for carrying biologically active substances and methods of production and use |
11/29/1995 | EP0683664A1 Taxol formulation |
11/29/1995 | CN1112443A Oral peptide capable of promoting nerve growth and its preparing method |
11/29/1995 | CN1112420A Orally administerable pharmaceutical formulations |
11/28/1995 | US5470974 Uncharged polynucleotide-binding polymers |
11/28/1995 | US5470911 Biocompatibility |
11/28/1995 | US5470884 Anti-acne compositions |
11/28/1995 | US5470880 Method of using citric acid for the treatment of wrinkles |
11/28/1995 | US5470848 Penetration enhancers for transdermal delivery of systemic agents |
11/28/1995 | US5470843 Carbohydrate-containing polymers, their preparation and use |
11/28/1995 | US5470842 Carbohydrate-based anti-inflammatory agents |
11/28/1995 | US5470840 Anti-inflammatory compounds and compositions |
11/28/1995 | US5470829 Slow release of a growth factor or hormone |
11/28/1995 | US5470589 Hardening agent for affected tissues of the digestive system |
11/28/1995 | US5470583 Nonionic surfactant surface modifier, phosphatide cloud point modifier, sterilization, small particles of theraputic or diagnostic agent |
11/28/1995 | US5470570 Removal of viruses, proteins and microorganisms from circulatory system, HIV treatment |
11/28/1995 | US5470551 Soft without sticky |
11/28/1995 | US5469854 Methods of preparing gas-filled liposomes |
11/28/1995 | CA2150204A1 Composition consisting of a dendrimer and an active substance occluded in the dendrimer, a process for the preparation of such a composition and a process for releasing the activesubstance |
11/23/1995 | WO1995031556A1 Glucan-binding proteins, and use thereof |
11/23/1995 | WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
11/23/1995 | WO1995031479A1 Methods and compositions for the dry powder formulation of interferons |
11/23/1995 | WO1995031459A1 Morpholino-subunit combinatorial library and method |
11/23/1995 | WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
11/23/1995 | WO1995031223A1 Medical polymer gel |
11/23/1995 | WO1995031218A1 Selenium conjugates for the preparation of free radical pharmaceuticals |
11/23/1995 | WO1995031217A1 Tocopherol compositions for delivery of biologically active agents |
11/23/1995 | WO1995031213A1 IFN-β LIQUID FORMULATIONS |
11/23/1995 | WO1995031211A1 Lacrimal gland specific emulsions for topical application to ocular tissue |
11/23/1995 | WO1995031210A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1) |
11/23/1995 | WO1995031203A1 Oral liquid alendronate formulations |
11/23/1995 | WO1995031201A1 Topical preparation containing aciclovir |
11/23/1995 | WO1995031193A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same |
11/23/1995 | WO1995031182A1 Narcotic containing aerosol formulation |
11/23/1995 | WO1995031181A1 Hepatocyte-selective oil-in-water emulsion |
11/23/1995 | WO1995031178A1 Mucoadhesive emulsions containing cyclodextrin |
11/23/1995 | CA2190502A1 Methods and compositions for the dry powder formulation of interferons |
11/23/1995 | CA2190465A1 Ifn-.beta. liquid formulations |
11/23/1995 | CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
11/23/1995 | CA2189970A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same |
11/22/1995 | EP0682948A1 Pharmaceutical composition containing guar gum and a neutralizing antacid |
11/22/1995 | EP0682944A1 Stable lyophilized formulation containing a protein and dosage kit |
11/22/1995 | EP0682942A1 Novel, percutaneously absorbable preparation |
11/22/1995 | EP0682941A2 Ointment carrier comprising hydrocarbons with vaseline structure |
11/22/1995 | EP0682528A1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane |
11/22/1995 | EP0682524A1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
11/22/1995 | EP0682520A1 Combination of a calcium channel blocker and an antioxydant for treating ischemic diseases |
11/22/1995 | EP0682512A1 Alkaline ophthalmic suspensions |
11/22/1995 | CN1112129A Partially acylated -cyclodextrins |
11/22/1995 | CN1112126A Polyamid-oligonucleotide derivative, preparation and application of same |
11/22/1995 | CN1112019A Novel process for the preparation of cetrorelix lyophilisate |
11/22/1995 | CN1111958A Method for making spiral algae sheet |
11/21/1995 | US5468847 Method of isolating and purifying a biomacromolecule |
11/21/1995 | US5468754 Anticarcinogenic agents |
11/21/1995 | US5468728 Administering peptide exhibiting motilin activity, a peptide lyric enzyme inhibitor and surfactant |
11/21/1995 | US5468505 Local delivery of fibrinolysis enhancing agents |
11/21/1995 | US5468481 Glycoside antigen peptides for autoimmune diseases |
11/21/1995 | US5468478 Conjugates of superoxide dismutage coupled to high molecular weight polyalkylene glycols |
11/21/1995 | US5468471 Sunscreen |
11/21/1995 | US5468465 Treated apatite particles for x-ray diagnostic imaging |
11/21/1995 | CA1337589C Unpleasant taste masking compositions and methods for preparing same |
11/18/1995 | CA2148724A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica |
11/16/1995 | WO1995030442A1 Programmable genotoxic agents and uses therefor |
11/16/1995 | WO1995030441A1 Composition containing a solubilized antibacterial agent |
11/16/1995 | WO1995030440A1 Keratin-storable antifungal composition for external use |
11/16/1995 | WO1995030425A1 Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions |
11/16/1995 | WO1995030423A2 Cancer treatment and metastasis prevention |
11/16/1995 | WO1995030422A1 Controlled-release dosage forms of azithromycin |
11/16/1995 | WO1995030420A1 Use of vitamin e tocopheryl derivatives in ophthalmic compositions |
11/16/1995 | WO1995026715A3 Use of fatty acid esters as bioadhesive substances |
11/16/1995 | DE4416674A1 Topische Zubereitung enthaltend Aciclovir The topical preparation containing acyclovir |
11/16/1995 | CA2186865A1 Programmable genotoxic agents and uses therefor |
11/16/1995 | CA2166722A1 Use of vitamin e tocopheryl derivatives in ophthalmic compositions |
11/15/1995 | EP0682006A1 Process for the preparation of a concentrate of esters of polyunsaturated fatty acids |
11/15/1995 | EP0681841A1 $i(IN VIVO) FREE-RADICAL GENERATOR |
11/15/1995 | EP0681833A2 Nasally administrable compositions |
11/15/1995 | EP0681830A1 Sunscreen compositions |
11/15/1995 | EP0681572A1 Cyclic imide thione activated polyalkylene oxides |
11/15/1995 | EP0681558A1 Stable sulfide compositions, uses, and process for preparation thereof. |
11/15/1995 | EP0681481A1 Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin |
11/15/1995 | EP0681475A1 Therapeutic inhibitors of vascular smooth muscle cells |
11/15/1995 | EP0681473A1 Compositions containing tandospirone or its analogs |
11/15/1995 | EP0681472A1 Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents |
11/15/1995 | EP0681471A1 Pharmaceutical compositions comprising cyclodextrin inclusion complexes of the compound ci-979 |
11/15/1995 | EP0681470A1 Recombinant living subunit vaccine composition and process for its preparation. |
11/15/1995 | EP0615446B1 Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation |
11/15/1995 | EP0560822B1 Method for the manufacture of a controlled release solid unit dosage form |
11/15/1995 | EP0489096B1 Pharmaceutical compositions and a device for administering the same |
11/15/1995 | CN1111532A Composition containing water unsolable or micro-solable compound which is raised with water solability |
11/15/1995 | CN1111531A Medical nano capsule freezing and drying protective agent |
11/15/1995 | CN1111510A Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
11/15/1995 | CN1111509A Protracted-release administration forms containing clindamycin palmitate |